Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?

BACKGROUND: The rising number of infections due to Severe Acute Respiratory Syndrome Coronavirus-2 (popularly known as COVID-19) has brought to the fore new antiviral drugs as possible treatments, including favipiravir. However, there is currently no data regarding the safety of this drug in patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Nephrol
Main Authors: Ozsurekci, Yasemin, Oygar, Pembe Derin, Gürlevik, Sibel Laçinel, Kesici, Selman, Ozen, Seza, Kurt Sukur, Eda Didem, Gülhan, Bora, Topaloglu, Rezan, Bayrakci, Benan, Cengiz, Ali Bülent
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8140325/
https://ncbi.nlm.nih.gov/pubmed/34021797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-021-05111-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados